Otwell AG, Stambough JB, Cherney SM, Blake L, Siegel ER, Mears SC. Does the type of lower extremity fracture affect long-term opioid usage? A meta-analysis. Arch Orthop Trauma Surg. 2024 Mar; 144(3):1221-1231.

Beletsky A, Music S, Liu C, Vickery K, Hurlock N, Winston N, Loomba M, Suvar T, Chen J, Gabriel RA. Long-Term Outcomes After Spinal Cord Stimulator Placement in Patients with Pre-procedural Active Opioid Use Versus Patients Who Were Opioid-Na?ve. Pain Physician. 2024 Jan; 27(1):69-77.

Fortney JC, Ratzliff AD, Blanchard BE, Johnson M, Ferro L, Austin EJ, Williams EC, Duncan MH, Merrill JO, Thomas J, Kitay B, Schoenbaum M, Heagerty PJ, Saxon AJ. Does Screening for Opioid Use Disorder in Primary Care Increase the Percentage of Patients With a New Diagnosis? Ann Intern Med. 2023 10; 176(10):1431-1433.

Austin EJ, Chen J, Briggs ES, Ferro L, Barry P, Heald A, Merrill JO, Curran GM, Saxon AJ, Fortney JC, Ratzliff AD, Williams EC. Integrating Opioid Use Disorder Treatment Into Primary Care Settings. JAMA Netw Open. 2023 08 01; 6(8):e2328627.

Tsai PF, Oliveto AH, Landes RD, Mancino MJ. Characteristics of patients undergoing medication-assisted -treatment for opioid use disorder and their interest in Tai Chi practice. J Opioid Manag. 2023 Jul-Aug; 19(4):329-341.

Tobacyk J, Parks BJ, Salazar P, Coward LU, Berquist MD, Gorman GS, Brents LK. Interaction between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome. Drug Alcohol Depend. 2023 08 01; 249:110832.

West KD, Ali MM, Blanco M, Natzke B, Nguyen L. Prenatal Substance Exposure and Neonatal Abstinence Syndrome: State Estimates from the 2016-2020 Transformed Medicaid Statistical Information System. Matern Child Health J. 2023 Dec; 27(Suppl 1):14-22.

Jones CM, Shoff C, Blanco C, Losby JL, Ling SM, Compton WM. Association of Receipt of Opioid Use Disorder-Related Telehealth Services and Medications for Opioid Use Disorder With Fatal Drug Overdoses Among Medicare Beneficiaries Before and During the COVID-19 Pandemic. JAMA Psychiatry. 2023 05 01; 80(5):508-514.

Shah NK, Chandler MW, Cetto AV, Luciani LL, Painter J, Bailey D. Retrospective Cohort Study of Safety Outcomes Associated with Opioid Rotations to Buprenorphine. J Pain Palliat Care Pharmacother. 2023 Sep; 37(3):234-245.

Thompson RG, Bollinger M, Mancino MJ, Hasin D, Han X, Bush KA, Kilts CD, James GA. Smartphone intervention to optimize medication-assisted treatment outcomes for opioid use disorder: study protocol for a randomized controlled trial. Trials. 2023 Apr 04; 24(1):255.

Gentry W, Stambough JB, Porter A, Barnes CL, Stronach BM, Mears SC. Surgical Approach Does Not Affect Chronic Opioid Usage After Total Hip Arthroplasty. J Arthroplasty. 2023 09; 38(9):1812-1816.

Nichols MA, Riley EG, Chao AS, Sales CG, Miller ML, Curran GM, Ott CA, Snyder ME, Hudmon KS. Opioid Use Disorder Curricular Content in US-Based Doctor of Pharmacy Programs. Am J Pharm Educ. 2023 06; 87(6):100061.

Devlin LA, Hu Z, Ounpraseuth S, Simon AE, Annett RD, Das A, Fuller JF, Higgins RD, Merhar SL, Smith PB, Crawford MM, Cottrell LE, Czynski AJ, Newman S, Paul DA, S?nchez PJ, Semmens EO, Smith MC, Whalen BL, Snowden JN, Young LW. The Influence of Mediators on the Relationship Between Antenatal Opioid Agonist Exposure and the Severity of Neonatal Opioid Withdrawal Syndrome. Matern Child Health J. 2023 Jun; 27(6):1030-1042.

Ware OD, Sweeney MM, Cunningham C, Umbricht A, Stitzer M, Dunn KE. Bupropion Slow Release vs Placebo With Adaptive Incentives for Cocaine Use Disorder in Persons Receiving Methadone for Opioid Use Disorder: A Randomized Clinical Trial. JAMA Netw Open. 2023 03 01; 6(3):e232278.

Acharya M, Hayes CJ, Li C, Painter JT, Dayer L, Martin BC. Comparative Study of Opioid Initiation With Tramadol, Short-acting Hydrocodone, or Short-acting Oxycodone on Opioid-related Adverse Outcomes Among Chronic Noncancer Pain Patients. Clin J Pain. 2023 Mar 01; 39(3):107-118.

Glass JE, Dorsey CN, Beatty T, Bobb JF, Wong ES, Palazzo L, King D, Mogk J, Stefanik-Guizlo K, Idu A, Key D, Fortney JC, Thomas R, McWethy AG, Caldeiro RM, Bradley KA. Study protocol for a factorial-randomized controlled trial evaluating the implementation, costs, effectiveness, and sustainment of digital therapeutics for substance use disorder in primary care (DIGITS Trial). Implement Sci. 2023 02 01; 18(1):3.

McKay M, Gorvine MM, Zaller N, Singh V, Goree J. Federal and Statewide Coverage for Opioid-Sparing Chronic Pain Treatments. Pain Physician. 2022 12; 25(9):E1457-E1466.

Ali MM, Creedon TB, Jacobus-Kantor L, Sherry TB. National trends in buprenorphine prescribing before and during the COVID-19 pandemic. J Subst Abuse Treat. 2023 01; 144:108923.

Costantino RC, Tilley LC, Gressler LE, Zarzabal LA, Vasquez CM, Peters S, Pakieser J, Highland KB, dosReis S. Naloxone Prescribing Associated With Reduced Emergency Department Visits in the Military Health System. Med Care. 2022 12 01; 60(12):901-909.

Nichols MA, Kepley KL, Rosko KS, Hudmon KS, Curran GM, Ott CA, Snyder ME, Miller ML. Community pharmacist-provided opioid intervention frequencies and barriers. J Am Pharm Assoc (2003). 2023 Jan-Feb; 63(1):336-342.

Jones CM, Shoff C, Hodges K, Blanco C, Losby JL, Ling SM, Compton WM. Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic. JAMA Psychiatry. 2022 10 01; 79(10):981-992.

Griffith PS, Brown LM, Lensing SY, Nahata R, Padala PR, Snow L, Milholland K, Mullins M. Opioid Use Disorder: Treatment Outcomes in U.S. Veterans. J Addict Nurs. 2022 Oct-Dec 01; 33(4):322-325.

Acharya M, Hayes CJ, Li C, Painter JT, Dayer L, Martin BC. Development of a potential opioid misuse measure from administrative dispensing data and contrasting opioid misuse among individuals on long-term tramadol, long-term short-acting hydrocodone or long-term short-acting oxycodone therapy in Arkansas. Curr Med Res Opin. 2022 11; 38(11):1947-1957.

Hayes CJ, Koonce RM, Gressler LE, Hu B, Williams JS, Martin BC. Association between opioid therapy trajectories and potential opioid-related adverse health events. Pharmacoepidemiol Drug Saf. 2022 10; 31(10):1075-1090.

Mackiewicz M, Brown RE, Price ET, Sargent L. Quality of life in older adults with opioid use disorder: A scoping review. Geriatr Nurs. 2022 Jul-Aug; 46:118-124.

Austin EJ, Briggs ES, Ferro L, Barry P, Heald A, Curran GM, Saxon AJ, Fortney J, Ratzliff AD, Williams EC. Integrating Routine Screening for Opioid Use Disorder into Primary Care Settings: Experiences from a National Cohort of Clinics. J Gen Intern Med. 2023 02; 38(2):332-340.

Hirata Y, Witt RG, Prakash LR, Arvide EM, Robinson KA, Gottumukkala V, Tzeng CD, Mansfield P, Badgwell BD, Ikoma N. Analysis of Opioid Use in Patients Undergoing Open Versus Robotic Gastrectomy. Ann Surg Oncol. 2022 Sep; 29(9):5861-5870.

Ali MM, Ghertner R. Is buprenorphine treatment availability associated with decreases in substantiated cases of child maltreatment? J Subst Abuse Treat. 2022 08; 139:108780.

Copeland LA, Pugh MJ, Bollinger MJ, Wang CP, Amuan ME, Rivera JC, Shireman PK. The VA vascular injury study: A glimpse at quality of care in Veterans with traumatic vascular injury repair. Injury. 2022 Jun; 53(6):1947-1953.

Lai H, Mubashir T, Shiwalkar N, Ahmad H, Balogh J, Williams G, Bauer C, Maroufy V. Association of pre-admission opioid abuse and/or dependence on major complications in traumatic brain injury (TBI) patients. J Clin Anesth. 2022 08; 79:110719.

Hereford TE, Porter A, Stambough JB, Cherney SM, Mears SC. Prevalence of Chronic Opioid Use in the Elderly After Hip Fracture Surgery. J Arthroplasty. 2022 07; 37(7S):S530-S535.

Featherall J, Anderson JT, Anderson LA, Bayless K, Anderson Z, Brooke BS, Gililland JM, Buys MJ. A Multidisciplinary Transitional Pain Management Program Is Associated With Reduced Opioid Dependence After Primary Total Joint Arthroplasty. J Arthroplasty. 2022 06; 37(6):1048-1053.

Oliveto AH, Wright P, Kumar N, Gokarakonda S, Fischer-Laycock I, Williams J, Thompson RG. Acceptability of a Game-Based Intervention to Prevent Adolescent Prescription Opioid Misuse. Games Health J. 2022 Apr; 11(2):104-116.

O'Brien PE, Mears SC, Siegel ER, Barnes CL, Stambough JB. Does In-Hospital Opioid Use Affect Opioid Consumption After Total Joint Arthroplasty? J Arthroplasty. 2022 05; 37(5):824-830.

Pro G, Hayes C, Brown CC, Goree J, Zaller N. Individual and Health Policy Factors Associated With Positive Heroin and Opioid Treatment Response: United States, 2018. Am J Public Health. 2022 02; 112(S1):S66-S76.

Fallin-Bennett A, Smid M, Salvador JG, Coker J, McKinney K, Weitzen S, Bonham C, Ashford K. Perceived Effect of Research on Clinical Care for Women With Opioid Use Disorder. J Obstet Gynecol Neonatal Nurs. 2022 03; 51(2):195-204.

Poehlmann JR, Stowe ZN, Godecker A, Xiong PT, Broman AT, Antony KM. The impact of preexisting maternal anxiety on pain and opioid use following cesarean delivery: a retrospective cohort study. Am J Obstet Gynecol MFM. 2022 05; 4(3):100576.

Hayes CJ, Cucciare MA, Martin BC, Hudson TJ, Bush K, Lo-Ciganic W, Yu H, Charron E, Gordon AJ. Using data science to improve outcomes for persons with opioid use disorder. Subst Abus. 2022; 43(1):956-963.

Hayes CJ, Krebs EE, Brown J, Li C, Hudson T, Martin BC. Impact of transitioning from long-term to intermittent opioid therapy on the development of opioid-related adverse outcomes: A retrospective cohort study. Drug Alcohol Depend. 2022 02 01; 231:109236.

Wells-Di Gregorio S, Ehrman S, Bartle-Haring S, Polder J, Marks D, Probst DR, Hartman AD, Adolph M, Taylor R. Prospective Study of a Novel Risk Stratification Process for Opioid-Related Harm Reduction in Cancer Patients Seen in an Outpatient Palliative Care Clinic. J Palliat Med. 2022 05; 25(5):783-792.

Saunders EC, Budney AJ, Cavazos-Rehg P, Scherer E, Marsch LA. Comparing the feasibility of four web-based recruitment strategies to evaluate the treatment preferences of rural and urban adults who misuse non-prescribed opioids. Prev Med. 2021 11; 152(Pt 2):106783.

Hawk K, Hoppe J, Ketcham E, LaPietra A, Moulin A, Nelson L, Schwarz E, Shahid S, Stader D, Wilson MP, D'Onofrio G. Consensus Recommendations on the Treatment of Opioid Use Disorder in the Emergency Department. Ann Emerg Med. 2021 09; 78(3):434-442.

Pro G, Montgomery BEE, Zaller N. Tailoring services in opioid treatment programs for patients involved in America's criminal justice system: national associations and variation by state and Medicaid expansion status. Subst Abuse Treat Prev Policy. 2021 06 19; 16(1):50.

Shah JR, Ramseyer A, Coker J. Peripartum management for women with opioid dependence. Curr Opin Anaesthesiol. 2021 Jun 01; 34(3):226-232.

Lin LA, Fortney JC, Bohnert ASB, Coughlin LN, Zhang L, Piette JD. Comparing telemedicine to in-person buprenorphine treatment in U.S. veterans with opioid use disorder. J Subst Abuse Treat. 2022 02; 133:108492.

Coker JL, Ray-Griffith SL, McLeod C, Han X, Mancino M, Kearns GL, Stowe ZN. Clearance of buprenorphine during pregnancy and neonatal outcomes. Arch Womens Ment Health. 2021 12; 24(6):933-939.

Ali MM, Dubenitz J. Suicidal behavior, opioid use disorder, and behavioral health treatment: Prevalence and correlates among adults in the United States 2015-2018. J Subst Abuse Treat. 2021 11; 130:108413.

Woody GE, Poole S, Yu E, Carroll J, Lynch KG. Extended release injectable naltrexone before vs. after release: A randomized trial of opioid addicted persons who are in prison. J Subst Abuse Treat. 2021 08; 127:108355.

Selva Kumar D, Peterson M, Zhang C, Fagan P, Nahvi S. The impact of menthol cigarette use on quit attempts and abstinence among smokers with opioid use disorder. Addict Behav. 2021 07; 118:106880.

Saunders EC, Moore SK, Walsh O, Metcalf SA, Budney AJ, Cavazos-Rehg P, Scherer E, Marsch LA. "It's way more than just writing a prescription": A qualitative study of preferences for integrated versus non-integrated treatment models among individuals with opioid use disorder. Addict Sci Clin Pract. 2021 01 27; 16(1):8.

Tong J, Chen Z, Duan R, Lo-Ciganic WH, Lyu T, Tao C, Merkel PA, Kranzler HR, Bian J, Chen Y. Identifying Clinical Risk Factors for Opioid Use Disorder using a Distributed Algorithm to Combine Real-World Data from a Large Clinical Data Research Network. AMIA Annu Symp Proc. 2020; 2020:1220-1229.

Chen SA, White RS, Tangel V, Gupta S, Stambough JB, Gaber-Baylis LK, Weinberg R. Preexisting Opioid Use Disorder and Outcomes After Lower Extremity Arthroplasty: A Multistate Analysis, 2007-2014. Pain Med. 2020 12 25; 21(12):3624-3634.

Mitchell MM, Schwartz RP, Choo TH, Pavlicova M, O'Grady KE, Gryczynski J, Stitzer ML, Nunes EV, Rotrosen J. An alternative analysis of illicit opioid use during treatment in a randomized trial of extended-release naltrexone versus buprenorphine-naloxone: A per-protocol and completers analysis. Drug Alcohol Depend. 2021 02 01; 219:108422.

Zaller N, Brinkley-Rubinstein L. MOUD Provision in Correctional Settings During Time of COVID-19: Prevention and Solutions. J Addict Med. 2020 12; 14(6):e290-e292.

Compton WM, Wiley T, Blanco C. The Importance of Learning Health Systems in Addressing the Opioid Crisis. J Gen Intern Med. 2020 12; 35(Suppl 3):891-894.

Pro G, Giano Z, Camplain R, Haberstroh S, Camplain C, Wheeler D, Hubach RD, Baldwin JA. The Role of State Medicaid Expansions in Integrating Comprehensive Mental Health Services into Opioid Treatment Programs: Differences Across the Rural/Urban Continuum. Community Ment Health J. 2021 08; 57(6):1017-1022.

Ray-Griffith S, Tharp E, Coker JL, Catlin D, Knight B, Stowe ZN. Buprenorphine Medication for Opioid Use Disorder: A Study of Factors Associated With Postpartum Treatment Retention. Am J Addict. 2021 01; 30(1):43-48.

Ghertner R, Ali MM. Increases in Providers With Buprenorphine Waivers in the United States From 2016 to 2019. Psychiatr Serv. 2020 09 01; 71(9):971.

Pro G, Utter J, Haberstroh S, Baldwin JA. Dual mental health diagnoses predict the receipt of medication-assisted opioid treatment: Associations moderated by state Medicaid expansion status, race/ethnicity and gender, and year. Drug Alcohol Depend. 2020 04 01; 209:107952.

Sanmartin MX, McKenna RM, Ali MM, Krebs JD. Racial Disparities in Payment Source of Opioid Use Disorder Treatment among Non-Incarcerated Justice-Involved Adults in the United States. J Ment Health Policy Econ. 2020 Mar 01; 23(1):19-25.

Acharya M, Chopra D, Hayes CJ, Teeter B, Martin BC. Cost-Effectiveness of Intranasal Naloxone Distribution to High-Risk Prescription Opioid Users. Value Health. 2020 04; 23(4):451-460.

Streck JM, Sigmon SC, Priest J, Bergeria CL, Davis DR, Hughes JR, Villanti AC, Tidey JW, Heil SH, Gaalema DE, Stitzer ML, Higgins ST. Investigating tobacco withdrawal in response to reduced nicotine cigarettes among smokers with opioid use disorder and other vulnerabilities. Exp Clin Psychopharmacol. 2020 Dec; 28(6):714-723.

Tang J, Landes RD. Some t-tests for N-of-1 trials with serial correlation. PLoS One. 2020; 15(2):e0228077.

Pro G, Utter J, Cram J, Baldwin J. Racial/Ethnic and Gender Differences in Associations of Medication-Assisted Therapy and Reduced Opioid Use between Outpatient Treatment Admission and Discharge. J Psychoactive Drugs. 2020 Apr-Jun; 52(2):186-194.

Saunders EC, Moore SK, Walsh O, Metcalf SA, Budney AJ, Scherer E, Marsch LA. Perceptions and preferences for long-acting injectable and implantable medications in comparison to short-acting medications for opioid use disorders. J Subst Abuse Treat. 2020 04; 111:54-66.

Lee SW, Shen J, Kim SJ, Chun SY, Kim P, Riaz J, Yoo JW, Hwang J. US Trends of Opioid-use Disorders and Associated Factors Among Hospitalized Patients With Spinal Conditions and Treatment From 2005 to 2014. Spine (Phila Pa 1976). 2020 Jan 15; 45(2):124-133.

Peterson LE, Morgan ZJ, Borders TF. Practice Predictors of Buprenorphine Prescribing by Family Physicians. J Am Board Fam Med. 2020 Jan-Feb; 33(1):118-123.

Meinhofer A, Hinde JM, Ali MM. Substance use disorder treatment services for pregnant and postpartum women in residential and outpatient settings. J Subst Abuse Treat. 2020 03; 110:9-17.

Hansen E, Nadagoundla C, Wang C, Miller A, Case AA. Buprenorphine for Cancer Pain in Patients With Nonmedical Opioid Use: A Retrospective Study at a Comprehensive Cancer Center. Am J Hosp Palliat Care. 2020 May; 37(5):350-353.

Derefinko KJ, Salgado Garc?a FI, Johnson KC, Hand S, Murphy JG, McDevitt-Murphy M, Suda KJ, Andrasik F, Bursac Z, Chiu CY, Talley K, Brooks JH. A randomized pilot program to reduce opioid use following dental surgery and increase safe medication return. Addict Behav. 2020 03; 102:106190.

McClellan C, Fingar KR, Ali MM, Olesiuk WJ, Mutter R, Gibson TB. Price elasticity of demand for buprenorphine/naloxone prescriptions. J Subst Abuse Treat. 2019 11; 106:4-11.

Bolin EH, Escalona-Vargas D, Daily JA, Siegel ER, Lowery CL, Coker J, Stowe ZN, Eswaran H. Magnetocardiographic identification of prolonged fetal corrected QT interval in women receiving treatment for opioid use disorder. J Obstet Gynaecol Res. 2019 Oct; 45(10):1989-1996.

Zaller N, Donadeo K, Coffey J, Zielinski M, Brinkley-Rubinstein L. Screening for Opioid Use Disorder in the Largest Jail in Arkansas: A Brief Report. J Correct Health Care. 2019 07; 25(3):214-218.

Ali MM, Tehrani AB, Mutter R, Henke RM, Cutler E, Pines JM, Mazer-Amirshahi M. Factors associated with potentially problematic opioid prescriptions among individuals with private insurance and medicaid. Addict Behav. 2019 11; 98:106016.

Young SG, Hayes CJ, Aram J, Tait MA. Doctor hopping and doctor shopping for prescription opioids associated with increased odds of high-risk use. Pharmacoepidemiol Drug Saf. 2019 08; 28(8):1117-1124.

Compton WM, Jones CM, Baldwin GT, Harding FM, Blanco C, Wargo EM. Targeting Youth to Prevent Later Substance Use Disorder: An Underutilized Response to the US Opioid Crisis. Am J Public Health. 2019 06; 109(S3):S185-S189.

Ali MM, Cutler E, Mutter R, Henke RM, O'Brien PL, Pines JM, Mazer-Amirshahi M, Diou-Cass J. Opioid Use Disorder and Prescribed Opioid Regimens: Evidence from Commercial and Medicaid Claims, 2005-2015. J Med Toxicol. 2019 07; 15(3):156-168.

Wilson MP, Cucciare MA, Porter A, Chalmers CE, Mullinax S, Mancino M, Oliveto AH. The utility of a statewide prescription drug-monitoring database vs the Current Opioid Misuse Measure for identifying drug-aberrant behaviors in emergency department patients already on opioids. Am J Emerg Med. 2020 03; 38(3):503-507.

Derefinko KJ, Salgado Garc?a FI, Talley KM, Bursac Z, Johnson KC, Murphy JG, McDevitt-Murphy ME, Andrasik F, Sumrok DD. Adverse childhood experiences predict opioid relapse during treatment among rural adults. Addict Behav. 2019 09; 96:171-174.

Chalmers CE, Mullinax S, Brennan J, Vilke GM, Oliveto AH, Wilson MP. Screening Tools Validated in the Outpatient Pain Management Setting Poorly Predict Opioid Misuse in the Emergency Department: A Pilot Study. J Emerg Med. 2019 Jun; 56(6):601-610.

Griffin BA, Caperton CO, Russell LN, Cabanlong CV, Wilson CD, Urquhart KR, Martins BS, Zita MD, Patton AL, Alund AW, Owens SM, Fantegrossi WE, Moran JH, Brents LK. In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome. J Pharmacol Exp Ther. 2019 07; 370(1):9-17.

Gressler LE, Shah S, Shaya FT. Association of Criminal Statutes for Opioid Use Disorder With Prevalence and Treatment Among Pregnant Women With Commercial Insurance in the United States. JAMA Netw Open. 2019 03 01; 2(3):e190338.

Ali MM, Henke RM, Mutter R, O'Brien PL, Cutler E, Mazer-Amirshahi M, Pines JM. Family member opioid prescriptions and opioid use disorder. Addict Behav. 2019 08; 95:58-63.

Shah A, Hayes CJ, Lakkad M, Martin BC. Impact of Medical Marijuana Legalization on Opioid Use, Chronic Opioid Use, and High-risk Opioid Use. J Gen Intern Med. 2019 08; 34(8):1419-1426.

Wen H, Borders TF, Cummings JR. Trends In Buprenorphine Prescribing By Physician Specialty. Health Aff (Millwood). 2019 01; 38(1):24-28.

Dayer LE, Painter JT, McCain K, King J, Cullen J, Foster HR. A recent history of opioid use in the US: Three decades of change. Subst Use Misuse. 2019; 54(2):331-339.

Novak P, Feder KA, Ali MM, Chen J. Behavioral health treatment utilization among individuals with co-occurring opioid use disorder and mental illness: Evidence from a national survey. J Subst Abuse Treat. 2019 03; 98:47-52.

Timko C, Cucciare MA. Commentary on Socias et al. (2018): Clinical research perspectives on cannabis use in opioid agonist treatment. Addiction. 2018 12; 113(12):2259-2260.

Coker JL, Catlin D, Ray-Griffith S, Knight B, Stowe ZN. Buprenorphine medication-assisted treatment during pregnancy: An exploratory factor analysis associated with adherence. Drug Alcohol Depend. 2018 11 01; 192:146-149.

Gressler LE, Titus-Glover D, Shaya FT. Treatment modalities for pregnant women with opioid use disorder. Lancet. 2018 08 18; 392(10147):551.

Han B, Compton WM, Blanco C, Jones CM. Correlates of Prescription Opioid Use, Misuse, Use Disorders, and Motivations for Misuse Among US Adults. J Clin Psychiatry. 2018 08 14; 79(5).

Yadlapalli JSK, Bommagani SB, Mahelona RD, Wan A, Gannon BM, Penthala NR, Dobretsov M, Crooks PA, Fantegrossi WE. Evaluation of morphine-like effects of the mixed mu/delta agonist morphine-6-O-sulfate in rats: Drug discrimination and physical dependence. Pharmacol Res Perspect. 2018 07; 6(4):e00403.

Escalona-Vargas D, Coker JL, Ray-Griffith S, Siegel ER, Lowery CL, Stowe ZN, Eswaran H. Fetal assessment in buprenorphine-maintained women using fetal magnetoencephalography: a pilot study. Addiction. 2018 10; 113(10):1895-1904.

Brinkley-Rubinstein L, Cloud D, Drucker E, Zaller N. Opioid Use Among Those Who Have Criminal Justice Experience: Harm Reduction Strategies to Lessen HIV Risk. Curr HIV/AIDS Rep. 2018 06; 15(3):255-258.

Hereford TE, Cryar KA, Edwards PK, Siegel ER, Barnes CL, Mears SC. Patients With Hip or Knee Arthritis Underreport Narcotic Usage. J Arthroplasty. 2018 10; 33(10):3113-3117.

Cryar KA, Hereford T, Edwards PK, Siegel E, Barnes CL, Mears SC. Preoperative Smoking and Narcotic, Benzodiazepine, and Tramadol Use are Risk Factors for Narcotic Use After Hip and Knee Arthroplasty. J Arthroplasty. 2018 09; 33(9):2774-2779.

Han B, Compton WM, Blanco C, Jones CM. Prescription Opioid Use, Misuse, and Use Disorders in U.S. Adults. Ann Intern Med. 2018 03 06; 168(5):383-384.

Hayes CJ, Li X, Li C, Shah A, Kathe N, Bhandari NR, Payakachat N. Health-Related Quality of Life among Chronic Opioid Users, Nonchronic Opioid Users, and Nonopioid Users with Chronic Noncancer Pain. Health Serv Res. 2018 10; 53(5):3329-3349.

Brinkley-Rubinstein L, Zaller N, Martino S, Cloud DH, McCauley E, Heise A, Seal D. Criminal justice continuum for opioid users at risk of overdose. Addict Behav. 2018 11; 86:104-110.

Brinkley-Rubinstein L, McKenzie M, Macmadu A, Larney S, Zaller N, Dauria E, Rich J. A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-release. Drug Alcohol Depend. 2018 03 01; 184:57-63.

Gomes T, Jain S, Paterson JM, Sketris I, Caetano P, Henry D. Trends and uptake of new formulations of controlled-release oxycodone in Canada. Pharmacoepidemiol Drug Saf. 2018 05; 27(5):520-525.

Olfson M, Wall M, Wang S, Crystal S, Blanco C. Service Use Preceding Opioid-Related Fatality. Am J Psychiatry. 2018 06 01; 175(6):538-544.

Joshi M, Bartter T, Joshi A. The Role of Science in the Opioid Crisis. N Engl J Med. 2017 11 02; 377(18):1797.

Han B, Compton WM, Blanco C, Crane E, Lee J, Jones CM. Prescription Opioid Use, Misuse, and Use Disorders in U.S. Adults: 2015 National Survey on Drug Use and Health. Ann Intern Med. 2017 Sep 05; 167(5):293-301.

Watkins KE, Paddock SM, Hudson TJ, Ounpraseuth S, Schrader AM, Hepner KA, Stein BD. Association between process measures and mortality in individuals with opioid use disorders. Drug Alcohol Depend. 2017 08 01; 177:307-314.

Wen H, Hockenberry JM, Borders TF, Druss BG. Impact of Medicaid Expansion on Medicaid-covered Utilization of Buprenorphine for Opioid Use Disorder Treatment. Med Care. 2017 04; 55(4):336-341.

Nienaber TA, James RK, Burke BL, Beavers J. Can Neonates Get the Munchies? Clin Pediatr (Phila). 2018 03; 57(3):358-360.

Higgins ST, Heil SH, Sigmon SC, Tidey JW, Gaalema DE, Stitzer ML, Durand H, Bunn JY, Priest JS, Arger CA, Miller ME, Bergeria CL, Davis DR, Streck JM, Zvorsky I, Redner R, Vandrey R, Pacek LR. Response to varying the nicotine content of cigarettes in vulnerable populations: an initial experimental examination of acute effects. Psychopharmacology (Berl). 2017 Jan; 234(1):89-98.

Kumar N, Stowe ZN, Han X, Mancino MJ. Impact of early childhood trauma on retention and phase advancement in an outpatient buprenorphine treatment program. Am J Addict. 2016 10; 25(7):542-8.

Tuten M, Shadur JM, Stitzer M, Jones HE. A Comparison of Reinforcement Based Treatment (RBT) versus RBT plus Recovery Housing (RBTRH). J Subst Abuse Treat. 2017 01; 72:48-55.

Adams J, Bledsoe GH, Armstrong JH. Are Pain Management Questions in Patient Satisfaction Surveys Driving the Opioid Epidemic? Am J Public Health. 2016 Jun; 106(6):985-6.

Naeger S, Ali MM, Mutter R, Mark TL, Hughey L. Prescriptions Filled Following an Opioid-Related Hospitalization. Psychiatr Serv. 2016 11 01; 67(11):1262-1264.

Kee JR, Smith RG, Barnes CL. Recognizing and Reducing the Risk of Opioid Misuse in Orthopaedic Practice. J Surg Orthop Adv. 2016 Winter; 25(4):238-243.

Vaughn MG, Nelson EJ, Salas-Wright CP, Qian Z, Schootman M. Racial and ethnic trends and correlates of non-medical use of prescription opioids among adolescents in the United States 2004-2013. J Psychiatr Res. 2016 Feb; 73:17-24.

Timko C, Schultz NR, Cucciare MA, Vittorio L, Garrison-Diehn C. Retention in medication-assisted treatment for opiate dependence: A systematic review. J Addict Dis. 2016; 35(1):22-35.

Rich JD, McKenzie M, Larney S, Wong JB, Tran L, Clarke J, Noska A, Reddy M, Zaller N. Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial. Lancet. 2015 Jul 25; 386(9991):350-9.

Cochran G, Stitzer M, Campbell AN, Hu MC, Vandrey R, Nunes EV. Web-based treatment for substance use disorders: differential effects by primary substance. Addict Behav. 2015 Jun; 45:191-4.

Raina S, Paydak H, Al-Lahham T, Shihabuddin BS. Methadone induced Torsades de Pointes mimicking seizures in clinical presentation. Am J Drug Alcohol Abuse. 2014 Nov; 40(6):490-2.

Vanderlip ER, Sullivan MD, Edlund MJ, Martin BC, Fortney J, Austen M, Williams JS, Hudson T. National study of discontinuation of long-term opioid therapy among veterans. Pain. 2014 Dec; 155(12):2673-2679.

Cobaugh DJ, Gainor C, Gaston CL, Kwong TC, Magnani B, McPherson ML, Painter JT, Krenzelok EP. The opioid abuse and misuse epidemic: implications for pharmacists in hospitals and health systems. Am J Health Syst Pharm. 2014 Sep 15; 71(18):1539-54.

Edlund MJ, Austen MA, Sullivan MD, Martin BC, Williams JS, Fortney JC, Hudson TJ. Patterns of opioid use for chronic noncancer pain in the Veterans Health Administration from 2009 to 2011. Pain. 2014 Nov; 155(11):2337-43.

Christensen DR, Landes RD, Jackson L, Marsch LA, Mancino MJ, Chopra MP, Bickel WK. Adding an Internet-delivered treatment to an efficacious treatment package for opioid dependence. J Consult Clin Psychol. 2014 Dec; 82(6):964-72.

Lewis ET, Cucciare MA, Trafton JA. What do patients do with unused opioid medications? Clin J Pain. 2014 Aug; 30(8):654-62.